Share Prices & Company Research

Stockbroking

Indivior

Current Price 471.77p Bid 472.60p Ask 472.70p Change 0.04%
Last Updated: 27/05/2018 16:48. Prices delayed by at least 15 minutes.
Call 0113 243 6941 or search for your local office

Company Overview

Indivior plc is a global specialty pharmaceutical company with a 20-year legacy of leadership in patient advocacy and health policy while providing education on evidence-based treatment models that have revolutionized modern addiction treatment. The name is the fusion of the words individual and endeavour, and the tagline Focus on you makes the Company's commitment clear. Indivior is dedicated to transforming addiction from a global human crisis to a recognized and treated chronic disease. Building on its global portfolio of opioid dependence treatments, Indivior has a strong pipeline of product candidates designed to both expand on its heritage in this category and address other chronic conditions and co-occurring disorders of addiction, including alcohol use disorder and schizophrenia. Headquartered in the United States in Richmond, VA, Indivior employs more than 900 individuals globally and its portfolio of products is available in over 40 countries worldwide.

Financial Highlights Year Ended 31/12/2017

Turnover
£1,093.00m
Operating Profit
£193.00m
Dividend Yield
0.00
Dividend Per Share
0.00
Dividend Cover
0.00
P/E Ratio
58.79

Key Personnel

Shaun Thaxter
Chief Executive Officer
Mark Wesley Crossley
Chief Financial Officer
Howard H Pien
Executive Chairman
Tatjana Anni Hilde May
Non-Executive Director
Lizabeth Herbst Zlatkus
Non-Executive Director
Dr Yvonne Greenstreet
Non-Executive Director
Dr Andrew Thomas McLellan
Non-Executive Director
Lorna Mary Southcombe Parker
Non-Executive Director
Daniel Joseph Phelan
Non-Executive Director
Christian Stanton Schade
Non-Executive Director
Daniel Tasse
Non-Executive Director

Stock Details

EPIC
INDV
ISIN
GB00BRS65X63
Shares in Issue
727,462,421
Market cap
£3,421.26m

Analyst Views (4)

Strong Buy
 
50.00%
Buy
 
0.00%
Hold
 
50.00%
Sell
 
0.00%
Strong Sell
 
0.00%
The above information represents a selection of the views published in the last 120 days by analysts. It is subject to change without notice and doesn't reflect view held by Redmayne Bentley and is not advice.

Price Summary

Mid Price
472.60p
Bid Price
472.60p
Ask Price
472.70p
Volume
1510419
Change Today
0.20p
% Change Today
0.04%
Open
471.40p
Previous Close
472.60p
Intraday High
479.78p
Intraday Low
468.63p
52 Week High
478.20p
52 Week Low
246.50p
52 week high and low figures quoted above are calculated from intraday price data.

Intra-Day Chart

Indivior Intra-day Chart

Indivior News

News in this section is provided by MoneyAM

Broker Forecast - Citigroup issues a broker note on Indivior Plc 15 May 2018 | 08:50 FTSE struggles to gain momentum 14 May 2018 | 11:54 FTSE held back by weakness in miners and oil stocks 14 May 2018 | 09:02 Indivior reaches settlement with Par Pharmaceutical 14 May 2018 | 08:10 Broker Forecast - Jefferies International issues a broker note on Indivior Plc 08 May 2018 | 08:20 Indivior profit falls as Suboxone cedes market share 02 May 2018 | 08:48 Uncertainty over May interest rate hike supports FTSE 20 Apr 2018 | 16:51 FTSE rises amid shifting rate expectations 20 Apr 2018 | 11:54 Indivior files new drug submission in Canada for opoid abuse treatment 20 Apr 2018 | 07:45 Broker Forecast - Jefferies International issues a broker note on Indivior Plc 09 Apr 2018 | 08:00 FTSE bounces back as trade fears ease 05 Apr 2018 | 08:36 Indivior files patent infringement lawsuits for Suboxone 05 Apr 2018 | 07:49 Broker Forecast - Morgan Stanley issues a broker note on Indivior Plc 03 Apr 2018 | 08:10 FTSE struggles to gain ground against stronger pound 23 Mar 2018 | 16:46 Broker Forecast - Numis issues a broker note on Indivior Plc 23 Mar 2018 | 12:20 FTSE resilient as trade war fears hit global markets 23 Mar 2018 | 11:52 Indivior warns 'material loss' of market share for Suboxone amid US court ruling 23 Mar 2018 | 08:39 Director Deals - Indivior Plc (INDV) 13 Mar 2018 | 16:05 Director Deals - Indivior Plc (INDV) 13 Mar 2018 | 16:05 Oil price fall fails to topple FTSE 15 Feb 2018 | 16:49 Indivior net income, revenue grow in 2017 15 Feb 2018 | 07:53 Indivior files patent infringement lawsuit for Suboxone 08 Feb 2018 | 09:04 Broker Forecast - RBC Capital Markets issues a broker note on Indivior Plc 26 Jan 2018 | 10:50 Indivior to present at US healthcare conference 04 Jan 2018 | 13:14 Indivior and Addex in strategic collaboration 03 Jan 2018 | 07:46 Indivior amends and extends debt facilities 19 Dec 2017 | 07:17 Indivior NDA for schizophrenia drug accepted by FDA 12 Dec 2017 | 08:06 Indivior to issue shares under LTIP 08 Dec 2017 | 08:13 OPEC oil production cut fails to lift FTSE 01 Dec 2017 | 16:46 FTSE falls amid Corbyn 'threat' to banks 01 Dec 2017 | 11:58

Assets (£m)

Data has been provided by MoneyAM

Reporting Date
31 Dec 2017
31 Dec 2016
Tangible Assets
54.0
27.0
Intangible Assets & Goodwill
92.0
83.0
Investments & Other Non-Current Assets
73.0
109.0
Total Non-Current Assets
219.0
219.0
Inventory
52.0
41.0
Trade & Receivables
278.0
227.0
Cash & Receivables
863.0
692.0
Other Current Assets & Assets Held for Resale
32.0
30.0
Total Assets
1,444.0
1,209.0

Liabilities (£m)

Data has been provided by MoneyAM

Reporting Date
31 Dec 2017
31 Dec 2016
Short Term Liabilities
854.0
1,030.0
Long Term Liabilities
793.0
474.0
Other Liabilities / Pension etc
0.0
0.0
Total Liabilities
1,647.0
1,504.0

Net Assets (£m)

Data has been provided by MoneyAM

Reporting Date
31 Dec 2017
31 Dec 2016
Net Assets
-203.0
-295.0

Equity (£m)

Data has been provided by MoneyAM

Reporting Date
31 Dec 2017
31 Dec 2016
Share Capital
72.0
72.0
Minority Interests
0.0
0.0
Retained Earnings
1,032.0
950.0
Share Premium Account
2.0
0.0
Other Equity
-1,309.0
-1,317.0
Total Equity
-203.0
-295.0

Cashflow (£m)

Data has been provided by MoneyAM

Reporting Date
31 Dec 2017
31 Dec 2016
Cashflow from Operating Activities
295.0
407.0
Cashflow Before Financing
252.0
260.0
Increase / Decrease in Cash
168.0
225.0

Income (£m)

Data has been provided by MoneyAM

Reporting Date
31 Dec 2017
31 Dec 2016
Turnover
1,093.0
1,058.0
Cost of Sales
104.0
107.0
Gross Profit
989.0
951.0
Operating Profit
193.0
149.0
Pre-Tax Profit
137.0
98.0
Profit / Loss for the Year
58.0
35.0

Dividend History

Data has been provided by MoneyAM

Period
Ex-Dividend Date
Payment Date
H2 Dividend
16 Jun 2016
29 Jul 2016
H1 Dividend
17 Sep 2015
23 Oct 2015
The value of your investments and the income from them may go down as well as up, and you could get back less than you invested.
We use cookies on this site to improve your experience and help us provide you with a better website. An explanation of the cookies we use and their purpose can be found within our Cookie Policy. Your continued use of this site means you consent to the use of cookies.